Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00715091Phase 4Completed
Phase 4, randomised, single-blind trial of diclofenac in ankylosing spondylitis (AS) (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Mean Radiographic Change of the Spine at 2 years. Started Sep 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00715091.